Virtu Financial’s Basel Medical BMGL Stock Holding History

Virtu Financial’s Portfolio BMGL Stock Details BMGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,816	Closed	-$61K	–	2413
2025 Q3	$61K	Buy	2,816 +1,468	+109%	+$36.8K	﹤0.01%	1107
2025 Q2	$29K	Buy	+1,348	New	+$59.3K	﹤0.01%	1213

Other funds holding BMGL

GSC

Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BIA

Bell Investment Advisors Oakland, California $639M AUM 13.28% 1-Year Est. Return

Virtu Financial's BMGL Position: Q4 2025 in Review

Virtu Financial sold out of Basel Medical (BMGL) in Q4 2025, closing a stake of 2,816 shares — an estimated $61K sold.

Virtu Financial first reported a position in BMGL in Q2 2025 and held it in 2 quarters. The position peaked at $61K in Q3 2025. 9 funds tracked by Wall St. Rank hold BMGL as of Q4 2025.

Virtu Financial reported no remaining Basel Medical position as of Q4 2025 after selling out during the quarter.
Virtu Financial sold 2,816 Basel Medical shares in Q4 2025, an estimated $61K.
Virtu Financial first reported a position in Basel Medical in Q2 2025 and held it in 2 quarters.
Virtu Financial's Basel Medical position peaked at $61K in Q3 2025.
9 funds tracked by Wall St. Rank held Basel Medical as of Q4 2025.

Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.